Precision medicine in Alzheimer’s disease: Where are we now and where are we going?
Dr Isaacson describes that a person’s genes and individual biology should be taken into account to better personalize care for Alzheimer’s disease.
Dr Isaacson has received honorarium/consultation fees from Neurotrack.